Sign Up to like & get recommendations! 0
Published in 2019 at "American Journal of Obstetrics and Gynecology"
DOI: 10.1016/j.ajog.2018.12.008
Abstract: Objective Data Amenorrhea is a polarizing noncontraceptive effect of the levonorgestrel intrauterine system. Composite amenorrhea prevalence estimates that summarize all clinical data for the first-year after insertion currently are not available. The purpose of this… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "Contraception"
DOI: 10.1016/j.contraception.2016.11.008
Abstract: This case series reports on the safety and efficacy of the levonorgestrel 52-mg intrauterine system in adolescent and young adult solid organ transplant recipients. All patients used the device for contraception, with no documented cases… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Contraception"
DOI: 10.1016/j.contraception.2020.01.015
Abstract: This case of an intra-abdominal levonorgestrel 52mg intrauterine system found three weeks after manual postplacental placement demonstrates the importance of proper insertion technique and ascertainment of fundal placement. Ultrasound guidance can be considered if fundal… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Obstetrics and Gynecology"
DOI: 10.1097/aog.0000000000003034
Abstract: A phase 3 study of a levonorgestrel 52-mg intrauterine system in U.S. females shows high 5-year contraceptive efficacy and low hormonal adverse effect rates. read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Journal of Obstetrics and Gynaecology Research"
DOI: 10.1111/jog.15062
Abstract: To evaluate the efficacy of levonorgestrel 52 mg intrauterine system for intermenstrual bleeding in patients with previous cesarean delivery scar defects (PCDSs). read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Revista da Associacao Medica Brasileira"
DOI: 10.1590/1806-9282.65.6.857
Abstract: OBJECTIVE To evaluate endocervical and vaginal environment changes in women using a levonorgestrel-releasing intrauterine system (LNG-IUS). METHODS A quasi-experimental study included sixty women who had an LNG-IUS inserted in the Family Planning Clinic of UNICAMP… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Wiadomosci lekarskie"
DOI: 10.36740/wlek202210106
Abstract: OBJECTIVE The aim: To compare satisfaction of women using oral contraception to satisfaction of women using the levonorgestrel-secreting intrauterine system. In the comparison the following factors were taken into account: comfort of use, menstrual cycle,… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Revista de Chimie"
DOI: 10.37358/rc.19.1.6884
Abstract: The study aimed to compare the effectiveness of conservative methods [Levonorgestrel (C21H28O2) � releasing intrauterine system (52 mg), endometrial ablation, hysteroscopy] vs. hysterectomy in perimenopausal bleeding. The study population was represented by 270 women addressed… read more here.